Quality Chemical Industries Ltd. has appointed Dr. Frances Philomena Namatovu as its executive director, effective April 16, 2025.
Namatovu, a pharmacist with more than 11 years of experience in the pharmaceutical industry, previously served as the Head of Regulatory Affairs and Pharmacovigilance at Quality Chemical Industries Ltd.
In that role, she was responsible for regulatory compliance, drug safety, and strategic business development. She has also been the company’s Qualified Person for Pharmacovigilance since 2020.
Also Read: Absa Uganda Appoints Moses Rutahigwa as Banking Director
The company noted that Namatovu has held leadership roles at Quality Chemical Industries Ltd., guiding the company through regulatory and business challenges in the East African Community, the Southern African Development Community, the Economic Community of West African States, and with the World Health Organization (WHO).
Namatovu holds a Master of Science Degree in Drug Development with Biobusiness from Aberdeen University in Scotland and a Bachelor of Pharmacy degree from Manipal University in Karnataka, India. She is a member of the Pharmaceutical Society of Uganda.
Emmanuel Katongole, chairman and co-founder of Quality Chemical Industries Ltd., said the board welcomes Namatovu and is confident she will contribute to the company’s growth and success.
Check also;
- Buganda Road Court Acquits 14 FDC Members in Dismissed Case
- Museveni Assigns Three Permanent Secretaries New Task
written by @enock katamba
- Mr. katamba Enock: Professional designer with experience in web designing who started this activity in 2022 at Kyambogo University . Contact me on : (+256-758287080)
Latest entries
Celebrity GossipMarch 24, 2026Ugandan Film Industry Mourns Actress Esteri Tebandeke
NationalMarch 24, 2026Six Ugandans Remanded in Shs12.6 Billion Cross-Border Fraud Case
SportsMarch 22, 2026Dominant Manchester City Beat Arsenal 2-0 to Lift Carabao Cup at Wembley
EntertainmentMarch 22, 2026Government Brings In Copyright Monitoring Devices – Says Joel Isabirye
